MoonLake Immunotherapeutics (MLTX) Free Cash Flow (QoQ) (2021 - 2026)
MoonLake Immunotherapeutics (MLTX) Free Cash Flow (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - |
| 10 | MoonLake Immunotherapeutics | 1.41 Bn | 1.05 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.74% |
| Dec 31, 2025 | -31.99% |
| Sep 30, 2025 | 18.31% |
| Jun 30, 2025 | -42.84% |
| Mar 31, 2025 | 21.53% |
| Dec 31, 2024 | -89.89% |
| Sep 30, 2024 | 8.14% |
| Jun 30, 2024 | -86.58% |
| Mar 31, 2024 | -21.09% |
| Dec 31, 2023 | -33.44% |
| Sep 30, 2023 | 23.92% |
| Jun 30, 2023 | -34.73% |
| Mar 31, 2023 | 22.18% |
| Dec 31, 2022 | -24.00% |
| Sep 30, 2022 | 54.95% |
| Jun 30, 2022 | -46.18% |
| Mar 31, 2022 | 59.68% |
| Dec 31, 2021 | -1,619.72% |
| Sep 30, 2021 | 92.00% |
| Jun 30, 2021 | -23,645.79% |